Aegerion raises $47.5M in IPO

Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) raised $47.5 million through the sale of 5 million shares at $9.50 in an IPO underwritten by Leerink; Lazard; Needham; Canaccord; and Collins Stewart. The deal came in below the proposed range of $14-$16 and values the company at $160.1 million. A $15 price would have raised $75 million and valued the company at $252.8 million. In August, the company filed for an IPO for the third time to raise up to $86.3 million. Aegerion filed to go public twice in 2007, but withdrew the proposals, citing market conditions. Aegerion was up $1.30 (14%) to $10.80 in its first day of trading on Friday. ...